This two-day training provides insight into the regulatory requirements for drug development from both the viewpoint of regulatory authorities as well as inspection bodies.
GMP & GDP training for pharma & biotech
Language(s):
2 days in total
Registration ends in 47 days.
To be able to apply tools and strategies for the development and testing of a product.
A basic understanding of the clinical and non clinical studies to understand their impact on product development, the risks, and to manage and mitigate them in relation to product quality.
To be able to assess the right and relevant information about the product to be able to release it for its use in a non clinical or clinical study.
To enhance knowledge of regulatory requirements and best practices for the development of a pharmaceutical product and its quality to be able to comprehend the regulatory landscape and apply that knowledge to ensure product quality, patient safety and compliance with standards.
To create an understanding of concepts and principles in pharmaceutical development to understand the risks, manage and mitigate them in the different stages of development.
11-06-2024
Hotel Mitland
Register
This module is part of a series called: Quality Management in Pharma and Biotech. This series is designed to give participants an in-depth understanding of the QP’s role and responsibilities. See the other modules in this series below.
Training certificate
Lunch buffet
Course dinner
17 Lectures
In-house training may be your best choice! We have more than 100 GxP training courses on demand.
Hit enter to search or ESC to close
Receive our free course brochure in your inbox, including all course updates! Download the course brochure and discover:
Please wait while you are redirected to the right page...